Zita Jobbagy
Kecskemet, BK 6000, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society.
Journal: Orphanet journal of rare diseases
Published: April 04, 2023
Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 13, 2022
Do Hungarian multiple sclerosis care units fulfil international criteria?
Journal: PloS one
Published: October 20, 2021
Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease.
Journal: Life (Basel, Switzerland)
Published: March 30, 2021
The long-term follow-up of enzyme replacement treatment in late onset Pompe disease
Journal: Ideggyogyaszati szemle
Published: June 25, 2020
A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.
Journal: European journal of neurology
Published: April 10, 2019
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
Journal: Multiple sclerosis and related disorders
Published: October 15, 2015
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Journal: Molecular immunology
Published: May 14, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026